Creatine is a natural nitrogenous guanidino compound involved in bioenergy metabolism. Although creatine has been shown to protect neurons of the central nervous system (CNS) from experimental hypoxia/ischemia, it remains unclear if creatine may also protect CNS axons, and if the potential axonal protection depends on glial cells. To evaluate the direct impact of creatine on CNS axons, cortical axons were cultured in a separate compartment from their somas and proximal neurites using a modified two-compartment culture device. Axons in the axon compartment were subjected to acute energy depletion, an in vitro model of white matter ischemia, by exposure to 6 mM sodium azide for 30 min in the absence of glucose and pyruvate. Energy depletion reduced axonal ATP by 65%, depolarized axonal resting potential, and damaged 75% of axons. Application of creatine (10 mM) to both compartments of the culture at 24 h prior to energy depletion significantly reduced axonal damage by 50%. In line with the role of creatine in the bioenergy metabolism, this application also alleviated the axonal ATP loss and depolarization. Inhibition of axonal depolarization by blocking sodium influx with tetrodotoxin also effectively reduced the axonal damage caused by energy depletion. Further study revealed that the creatine effect was independent of glial cells, as axonal protection was sustained even when creatine was applied only to the axon compartment (free from somas and glial cells) for as little as 2 h. In contrast, application of creatine after energy depletion did not protect axons. The data provide the first evidence that creatine pretreatment may directly protect CNS axons from energy deficiency.
Introduction
The mammalian brain has high and variable energy demands but low reserves and is vulnerable to the hypoxic/ischemic injury that deprives energy. Creatine (N-aminoiminomethyl-N-methylglycine) is a natural guanidino compound involved in bioenergy metabolism via creatine kinase (CK). CK catalyzes the reversible reaction that converts creatine and ATP into phosphocreatine (PCr) and ADP. PCr is generated at the sites of ATP production, and then diffuses to and accumulates at the sites of ATP consumption, where it reproduces ATP via localized CK independent of oxygen and glucose. Because creatine via CK/PCr system provides a read-to-release high energy phosphate pool at the sites of energy consumption, it has been proposed that creatine may not only play a particular essential role in brain energy transfer and buffering under normal conditions, but also replenish brain ATP during hypoxia/ischemia and therefore reduce brain injury (for reviews, see Adhihetty and Beal, 2008; Andres et al., 2008; Perasso et al., 2011; Wallimann et al., 1992; Wyss and Kaddurah-Daouk, 2000) .
In agreement with this proposal, earlier in vitro studies have demonstrated the neuroprotective effect of creatine pretreatment against anoxic/hypoxic damage (Balestrino et al., 1999; Carter et al., 1995; Lipton and Whittingham, 1982; Luhmann and Heinemann, 1992) and oxygen and glucose deprivation (Okada and Yoneda, 1983) in adult brain slices as well as isolated CNS neurons (Zapara et al., 2004) . The creatine mediated neuroprotection is creatine transporter dependent (Lunardi et al., 2006) and coupled with increased levels of PCr, reduced rates of ATP reduction (Balestrino et al., 1999 (Balestrino et al., , 2002 Carter et al., 1995; Lipton and Whittingham, 1982; Okada and Yoneda, 1983) , and delayed membrane depolarization (Balestrino et al., 1999; Zapara et al., 2004) . Despite these convincing in vitro findings, the in vivo effects of creatine on ischemic brain injury are controversial (Prass et al., 2007; Wick et al., 1999; Zhu et al., 2004) . This controversy may be at least in part due to the poor penetration of creatine through the blood brain barrier (Perasso et al., 2003) . It has been reported that, when applied introcerebroventricularly, creatine is neuroprotective in experimental cerebral ischemia (Balestrino et al., 2002; Lensman et al., 2006; Rebaudo et al., 2000) . Recently, a creatine-derived compound Neurobiology of Disease 47 (2012) [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] Abbreviations: AUC, Area under the curve; CNS, central nervous system; CK, creatine kinase; DFI, Dibac4(3) fluorescence intensity; Dibac4(3), bis(1,3-dibutylbarbituric acid) trimethine oxonol; DIV, days in vitro; ΔΨ axon , membrane potential of axon; PCr, phosphocreatine; PDMS, polydimethylsiloxane; ROI, region of interest; TTX, tetrodotoxin. 
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